Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Chinese company Genertec Universal Medical Group has launched a $600m dual-currency loan into syndication. -
Drug developer SK Biopharmaceuticals priced its IPO high last Friday, netting W959.3bn ($792m), according to a source close to the deal.
-
In this round-up, the Chinese capital of Beijing conducts nucleic acid tests for Covid-19 on 2.3m local residents, the central bank leaves the benchmark lending rate unchanged for June, and a subsidiary of AIA is set to become China’s first wholly foreign owned life insurance company.
-
US investment managers GMO and Greylock will again unite to begin negotiations with Belize after the government said on Wednesday it wanted to delay all bond payments until February.
-
Peru's largest commercial lender Banco de Crédito del Perú (BCP) will begin fixed income investor calls on Monday as it contemplates a tier two capital bond issue, just two weeks after parent company Credicorp issued a debut $500m senior deal.
-
It has been a long time coming. Social impact bonds, in which the investor's return is based on the outcome of a social project, were invented 10 years ago. This week, one was issued for the first time by an organisation recognised as a full member of the mainstream European capital markets.
